Compare DRCT & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRCT | PAVM |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | 107 |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 9.1M |
| IPO Year | 2021 | N/A |
| Metric | DRCT | PAVM |
|---|---|---|
| Price | $0.76 | $8.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $330.00 | ★ $510.00 |
| AVG Volume (30 Days) | ★ 113.3K | 13.6K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,288,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $58.17 | $450.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.04 | $0.21 |
| 52 Week High | $6.04 | $28.44 |
| Indicator | DRCT | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 34.68 | 37.71 |
| Support Level | $0.50 | $8.43 |
| Resistance Level | $0.79 | $9.26 |
| Average True Range (ATR) | 0.08 | 0.54 |
| MACD | -0.00 | -0.25 |
| Stochastic Oscillator | 13.86 | 10.40 |
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.